Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation.
Brian FeingoldKirsten Rose-FelkerShawn C WestSusan A MillerMatthew D ZinnPublished in: Clinical transplantation (2023)
dd-cfDNA-led surveillance shows promise as a less invasive and cost saving alternative to EMB-led surveillance among pediatric and young adult HT recipients.